Homelife sciences

life sciences

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, BLI, ISO, CBIO

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, BLI, ISO, CBIO

December 29, 2022

Acer Therapeutics Compliant with All Nasdaq Listing Criteria

Acer Therapeutics Compliant with All Nasdaq Listing Criteria

December 29, 2022

New Strong Buy Stocks for December 29th

New Strong Buy Stocks for December 29th

December 29, 2022

Lifshitz Law PLLC Announces Investigations of CBIO, ISO, BLI, and APEN

Lifshitz Law PLLC Announces Investigations of CBIO, ISO, BLI, and APEN

December 28, 2022

Acer Therapeutics Inc. (ACER) Upgraded to Strong Buy: What Does It Mean for the Stock?

Acer Therapeutics Inc. (ACER) Upgraded to Strong Buy: What Does It Mean for the Stock?

December 28, 2022

Has CTI BioPharma (CTIC) Outpaced Other Medical Stocks This Year?

Has CTI BioPharma (CTIC) Outpaced Other Medical Stocks This Year?

December 28, 2022

CLASS ACTION UPDATE for SEDG, EIGR and TWST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

CLASS ACTION UPDATE for SEDG, EIGR and TWST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

December 28, 2022

After Plunging -30.6% in 4 Weeks, Here’s Why the Trend Might Reverse for Citius Pharmaceuticals, Inc. (CTXR)

After Plunging -30.6% in 4 Weeks, Here’s Why the Trend Might Reverse for Citius Pharmaceuticals, Inc. (CTXR)

December 28, 2022

ACER Down Despite FDA Nod for Urea Cycle Disorders Drug

ACER Down Despite FDA Nod for Urea Cycle Disorders Drug

December 28, 2022

Aridis Pharmaceuticals to Discuss Topline Data from Phase 3 Study of AR-301 During Corporate Update Call on January 25

Aridis Pharmaceuticals to Discuss Topline Data from Phase 3 Study of AR-301 During Corporate Update Call on January 25

December 28, 2022

« 1 … 4 5 6 7 8 … 557 »